Pharmaceutical

Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.
Read the original article

Tags:

Previous Article

Frontotemporal Dementia (FTD) drugs in development, 2024

Next Article

Siemens Healthineers to Acquire Novartis’ European Radiodiagnostic Production Ne...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14

HPV vaccine study finds zero cases of cervical cancer a...

Jan 26, 2024

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Fosun Pharma and IFC to build new drug manufacturing pl...

Jun 7, 2023

STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs

STAT+: Pharmalittle: Woodcock to retire from the FDA; A...

Nov 17, 2023